Trial · NCT02515630
Results by group421
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 421
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Transfusion Independence Response by Week 24 | Total | 34.1 | 90% Confidence Interval 22.0 to 48.1 | percentage of subjects | |
| Transfusion Response Rate by Week 24 | Total | 39.0 | 90% Confidence Interval 26.2 to 53.1 | percentage of subjects | |
| Splenic Response Rate at Week 24 | Total | 12.2 | 90% Confidence Interval 4.9 to 23.9 | percentage of subjects | |
| Response Rate in Total Symptom Score (TSS) at Week 24 | Total | 15.8 | 90% Confidence Interval 7.1 to 28.8 | percentage of subjects | |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Responders | Baseline | -1.7 | Inter-Quartile Range -2.1 to 4.7 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Non-Responders | Baseline | 0.1 | Inter-Quartile Range -3.3 to 4.5 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Total | Baseline | 0.0 | Inter-Quartile Range -3.3 to 4.6 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Responders | Day 1 | -4.8 | Inter-Quartile Range -10.2 to -1.4 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Non-Responders | Day 1 | -11.2 | Inter-Quartile Range -16.0 to -5.8 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Total | Day 1 | -8.6 | Inter-Quartile Range -14.4 to -3.3 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Responders | Week 2 | -4.9 | Inter-Quartile Range -9.1 to -0.4 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Non-Responders | Week 2 | -6.7 | Inter-Quartile Range -11.3 to -1.2 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Total | Week 2 | -6.3 | Inter-Quartile Range -9.2 to -0.7 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Responders | Week 4 | -2.6 | Inter-Quartile Range -8.5 to 0.1 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Non-Responders | Week 4 | -7.4 | Inter-Quartile Range -9.6 to -0.9 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Total | Week 4 | -5.4 | Inter-Quartile Range -9.6 to 0.1 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Responders | Week 8 | -2.9 | Inter-Quartile Range -7.3 to -0.9 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Non-Responders | Week 8 | -5.2 | Inter-Quartile Range -17.7 to 2.1 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Total | Week 8 | -4.4 | Inter-Quartile Range -10.9 to -0.6 | nM |
| Change in Markers of Iron Metabolism and Anemia - Change From Baseline in Hepcidin Daily Change | Transfusion Independence Responders | Week 12 | -1.4 | Inter-Quartile Range -6.8 to 0.7 | nM |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02515630/results